Why is amlodipine used to treat hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amlodipine for Hypertension Treatment

Amlodipine is a first-line antihypertensive agent that effectively lowers blood pressure by inhibiting calcium influx into vascular smooth muscle cells, resulting in vasodilation and reduced peripheral vascular resistance. 1

Mechanism of Action

  • Amlodipine is a dihydropyridine calcium channel blocker that selectively inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle 1
  • It has a greater effect on vascular smooth muscle cells than on cardiac muscle cells, producing vasodilation that reduces peripheral vascular resistance and blood pressure 1
  • The long half-life (35-50 hours) and duration of action allows for once-daily dosing with sustained 24-hour blood pressure control 2

Clinical Efficacy

  • Amlodipine effectively reduces both systolic and diastolic blood pressure, with dose-dependent effects starting at 2.5 mg and optimal effects typically seen at 5-10 mg daily 3
  • In the ALLHAT trial, amlodipine was equally effective as chlorthalidone (a thiazide diuretic) in preventing coronary heart disease mortality and morbidity 4
  • In the ASCOT trial, amlodipine-based therapy demonstrated superiority over atenolol-based therapy in reducing stroke and mortality 4
  • The Anglo-Scandinavian Cardiac Outcomes Trial showed that amlodipine-based therapy (with perindopril added as needed) reduced the incidence of fatal and nonfatal strokes by 25% compared to atenolol-based therapy in diabetic patients 4

Advantages in Special Populations

  • Amlodipine is effective in patients with diabetes, showing significant cardiovascular event reduction in this high-risk population 4
  • It is particularly useful in elderly patients due to its ability to control blood pressure and protect against stroke and myocardial infarction 2
  • In heart failure patients with persistent hypertension despite treatment with ACE inhibitors, beta-blockers, and mineralocorticoid receptor antagonists, amlodipine is recommended as a step 3 agent 4

Combination Therapy

  • Amlodipine works effectively in combination with other antihypertensive agents, including ACE inhibitors, ARBs, beta-blockers, and thiazide diuretics 5
  • The ACCOMPLISH trial demonstrated that the combination of an ACE inhibitor with amlodipine was superior to an ACE inhibitor with hydrochlorothiazide in reducing cardiovascular events in high-risk hypertensive patients 6
  • In the ALLHAT study, many patients required multiple drugs to achieve blood pressure control, highlighting the importance of combination therapy in managing hypertension 4

Safety Profile

  • Amlodipine is generally well-tolerated with a favorable safety profile 3
  • Common side effects include peripheral edema, headache, flushing, and dizziness 1
  • Unlike some calcium channel blockers (diltiazem and verapamil), amlodipine does not have significant negative inotropic effects at therapeutic doses 1
  • Amlodipine does not significantly alter heart rate or electrocardiographic parameters when used alone or in combination with beta-blockers 1

Clinical Considerations and Caveats

  • Starting dose is typically 5 mg once daily, with adjustment to 10 mg if necessary for blood pressure control 5
  • Amlodipine can be taken with or without food, making it convenient for patient adherence 1
  • The long half-life provides a forgiving pharmacokinetic profile, maintaining blood pressure control even if a dose is occasionally missed 2
  • While amlodipine is effective for hypertension, negatively inotropic CCBs (diltiazem and verapamil) should not be used to treat hypertension in patients with heart failure with reduced ejection fraction 4

Outcomes Benefits

  • Lowering blood pressure with amlodipine reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions 1
  • In the VALUE trial, amlodipine was compared to valsartan and showed similar efficacy in preventing cardiac events and death 4
  • The drug's ability to reduce blood pressure variability may contribute to its cardiovascular protective effects beyond simple blood pressure reduction 2

In conclusion, amlodipine is a highly effective antihypertensive agent with proven benefits for cardiovascular outcomes, making it an excellent choice for first-line treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents.

References

Research

Amlodipine in the current management of hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amlodipine: an effective once-daily antihypertensive agent.

Journal of human hypertension, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.